Debiotech is your partner for the development of highly innovative medical devices for therapeutic and diagnostic purposes :
Disposable programmable micropumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cycler for peritoneal dialysis, flow regulators, nano delivery systems...

Debiotech is also a R&D organisation which integrates today the best industrial skills and numerous collaborations with industrial groups and R&D centers for the quickest conversion of technical innovations into products.

Debiotech’s Insulin Nanopump™ is made of two parts: a permanent part that contains the electronics and a disposable part with the reservoir and the pumping mechanism. It has a total volume of 65mm x 38mm x 11mm (27ml) with an insulin reservoir capacity of 3ml and the permanent part attached. With such a small size, it can be hidden under the clothes and makes the disease almost invisible. Size is often perceived as a major issue for patients: pumps are heavy and cumbersome. The Insulin Nanopump™ is up to five times smaller than today’s pumps and therefore represents a clear progress for the patients’ Quality of Life.

The MEMS technology used in the Insulin Nanopump™ allows a very tight control of the pumping mechanism. Each pump actuation injects only 200 nanoliters of drug, and reproducibility is better than 2%, bringing it very close to physiological delivery of insulin. This precise control may also allow the use of more concentrated insulin, once available on the market. It should also extend the use of pumps for children who have low needs of insulin, and where injection must be especially well controlled. On the longer run, it may be combined with a continuous glucose monitoring system and open the way to the artificial pancreas.